Re: Precedence in Gene Therapy Pricing
|
4
|
Resverlogix Corp.
|
Jan 04, 2018 02:02AM
|
Re: Presentation
|
5
|
Resverlogix Corp.
|
May 13, 2021 06:52PM
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
May 13, 2021 06:56PM
|
Re: Presentation
|
6
|
Resverlogix Corp.
|
Jun 20, 2017 03:16AM
|
Re: Presentation
|
2
|
Zenith Epigenetics
|
Nov 03, 2017 04:23PM
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 16, 2021 11:51PM
|
Re: Presentation is up
|
4
|
Zenith Epigenetics
|
Jan 09, 2018 01:49PM
|
Re: Presentation May 12th
|
3
|
Resverlogix Corp.
|
May 09, 2021 04:17PM
|
Re: Presentation slides are up
|
6
|
Zenith Epigenetics
|
Jun 18, 2020 12:06PM
|
Re: Presentations & Events
|
3
|
Resverlogix Corp.
|
Jan 05, 2024 04:26PM
|
Re: Presentations-FYI...
|
4
|
Resverlogix Corp.
|
Jan 09, 2018 11:37AM
|
Re: Pretty much as expected
|
3
|
Resverlogix Corp.
|
Sep 17, 2019 03:03AM
|
Re: Pretty quiet on the Zenith front,
|
4
|
Zenith Epigenetics
|
Aug 05, 2018 09:34PM
|
Re: Preview Part II....
|
4
|
Resverlogix Corp.
|
Mar 30, 2017 10:25PM
|
Re: Preview Part II....
|
3
|
Resverlogix Corp.
|
Mar 30, 2017 10:36PM
|
Re: Price boxed in....
|
5
|
Resverlogix Corp.
|
Jan 28, 2019 10:34AM
|
Re: Price of ROFR for USA
|
2
|
Resverlogix Corp.
|
Feb 04, 2019 08:10AM
|
Re: Price Spike
|
2
|
Resverlogix Corp.
|
Oct 29, 2021 04:12PM
|
Re: Priceless on I.V. Regarding Zenith
|
3
|
Zenith Epigenetics
|
Apr 09, 2017 01:08PM
|
Re: Primary endpoint: Time vs Absolute Numbers
|
4
|
Resverlogix Corp.
|
Nov 19, 2018 01:39PM
|